首页|肿瘤微环境促进去势抵抗性前列腺癌进展的分子机制研究

肿瘤微环境促进去势抵抗性前列腺癌进展的分子机制研究

扫码查看
目的 探索前列腺癌获得去势抵抗性转移能力的分子机制.方法 采集、分离和测定健康志愿者(Control组)、原位前列腺癌(Local PC组)和去势抵抗性前列腺癌(mCRPC组)患者外周静脉血外泌体中微小RNA(miR)-130a的水平.收集上述前列腺患者癌组织,流式细胞术测定癌组织浸润M2样巨噬细胞比例.Western blot测定癌组织单核细胞趋化蛋白诱导蛋白3(MCPIP3)表达水平.酶联免疫吸附试验法测定癌组织中肿瘤坏死因子-α(TNF-α)和白介素-17A(IL-17A)水平.体外建立小鼠巨噬细胞RAW264.7细胞和人前列腺癌LNCaP细胞共培养体系.添加脂多糖(LPS)和白介素-4(IL-4)分别诱导RAW264.7细胞发生M1和M2极化.测定共培养体系中LNCaP细胞在有/无恩杂鲁胺情况下的增殖能力.结果 与Control组比较,mCRPC组血浆外泌体中miR-130a相对表达水平显著升高(P<0.05),Local PC组差异无统计学意义(P>0.05).与Local PC组比较,mCRPC组血浆外泌体中miR-130a相对表达水平显著升高,癌组织中浸润的M2样巨噬细胞数量所占百分比增多,癌组织中MCPIP3的相对表达水平降低,IL-17A水平上调(P<0.05),TNF-α水平差异无统计学意义(P>0.05).与M2样巨噬细胞共培养的LNCaP细胞增殖和去势抵抗性增殖能力高于与M1样巨噬细胞共培养的LNCaP细胞.结论 前列腺癌细胞通过外泌体释放高水平的miR-130a改变肿瘤微环境,引起巨噬细胞M2样极化并大量浸润癌组织,同时释放高水平IL-17A,形成促前列腺癌获得去势抵抗性生长和转移的肿瘤免疫微环境.
Study of molecular mechanism of tumor microenvironment promoting metastatic castration resistant prostate cancer progression
Objective To explore the molecular mechanism of prostate cancer's acquired castration resistant metastasis ability.Methods MiR-130a levels in exosomes derived from peripheral blood samples of healthy volunteers(Control group),local prostate cancer(Local PC group)patients and metastatic castration resistant prostate cancer(mCRPC group)patients were collected,isolated and determined.The cancer tissue of the above prostate patients was collected.The proportion of M2-like macrophages infiltrating in the cancer tissues were measured by flow cytometry.Monocyte chemotactic protein-induced protein 3(MCPIP3)expression levels in cancer tissues were determined by western blot.The levels of tumor necrosis factor-α(TNF-α)and interleukin-17A(IL-17A)in cancer tissues were measured by enzyme-linked immunosorbent assay(ELISA).In vitro co-cultured system of mouse RAW264.7 macrophages and human prostate cancer LNCaP cells was established.Lipopolysaccharide(LPS)and IL-4 were used to induce RAW264.7 cells Ml and M2 polarization,respectively.The proliferative ability of LNCaP cells in co-cultured system was determined in the presence or absence of enheterulamine.Results Compared with Control group,the relative expression level of miR-130a in exosomes of patients in mCRPC group were significantly increased(P<0.05),but there was no significant difference in patients of Local PC group(P>0.05).Compared with the patients in Local PC group,the relative level of miR-130a in plasma derived exosomes of mCRPC group was significantly increased,the percentage of M2-like macrophages infiltrating in the cancer tissues,the relative expression level of MCPIP3 and the level of IL-17A were up-regulated in cancer tissues(P<0.05),while there was no significant difference in the level of TNF-α(P>0.05).The proliferative and castration resistant proliferative ability of LNCaP cells in co-cultured system with M2-like macrophages were higher than that of LNCaP cells in co-cultured system with M1-like macrophages.Conclusions Prostate cancer cells released high levels of miR-130a through exosomes to change the tumor microenvironment,and to induce macrophages M2-like polarization and extensively infiltrated cancer tissues,with releasing high level of IL-17A,so as to form a tumor immune microenvironment that promotes prostate cancer obtaining castration resistant growth and metastasis.

Prostate cancerCastration resistant metastasisTumor microenvironmentMicroRNA-130aMonocyte chemotactic protein-induced protein 3Interleukin-17A

陈善苗、刘守磊、李耀军、罗晓

展开 >

桐乡市第一人民医院泌尿外科,浙江桐乡 314500

前列腺癌 去势抵抗性转移 肿瘤微环境 微小RNA-130a 单核细胞趋化蛋白诱导蛋白3 白介素-17A

2022年浙江省卫生科技计划临床研究应用项目

2022KY1277

2024

中国性科学
中国性学会

中国性科学

CSTPCD
影响因子:1.394
ISSN:1672-1993
年,卷(期):2024.33(6)
  • 2